Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Anastasia, Luigi  [Clear All Filters]
2014
Bergante S, Torretta E, Creo P, Sessarego N, Papini N, Piccoli M, Fania C, Cirillo F, Conforti E, Ghiroldi A, et al. Gangliosides as a potential new class of stem cell markers: the case of GD1a in human bone marrow stem cells. J Lipid Res. 2014.
2020
Ciconte G, Monasky MM, Santinelli V, Micaglio E, Vicedomini G, Anastasia L, Negro G, Borrelli V, Giannelli L, Santini F, et al. Brugada syndrome genetics is associated with phenotype severity. Eur Heart J. 2020.
Mingione A, Cas MDei, Bonezzi F, Caretti A, Piccoli M, Anastasia L, Ghidoni R, Paroni R, Signorelli P. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis. Cell Physiol Biochem. 2020;54(1):110-125.
Palmisano A, Piccoli M, Monti CBeatrice, Canu T, Cirillo F, Napolitano A, Perani L, Signorelli P, Vignale D, Anastasia L, et al. Single-shot morpho-functional and structural characterization of the left-ventricle in a mouse model of acute ischemia-reperfusion injury with an optimized 3D IntraGated cine FLASH sequence at 7T MR. Magn Reson Imaging. 2020.
2023
La Rocca P, Lavota I, Piccoli M, Cirillo F, Ghiroldi A, Ciconte G, Pappone C, Allevi P, Rota P, Anastasia L. Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC-MS: relationship between detection and stability. Glycoconj J. 2023.
Melo L, Ciconte G, Christy A, Vicedomini G, Anastasia L, Pappone C, Grant E. Deep learning unmasks the ECG signature of Brugada syndrome. PNAS Nexus. 2023;2(11):pgad327.
Rota P, La Rocca P, Bonfante F, Pagliari M, Piccoli M, Cirillo F, Ghiroldi A, Franco V, Pappone C, Allevi P, et al. Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses. ACS Infect Dis. 2023.
Rota P, La Rocca P, Bonfante F, Pagliari M, Cirillo F, Piccoli M, Ghiroldi A, Franco V, Pappone C, Allevi P, et al. Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site. ACS Med Chem Lett. 2023;14(10):1383-1388.